| [1] |
Chawla LS, Eggers PW, Star RA, et al. Acute kidney injury and chronic kidney disease as interconnected syndromes [J]. N Engl J Med, 2014, 371(1): 58-66.
|
| [2] |
See EJ, Jayasinghe K, Glassford N, et al. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure [J]. Kidney Int, 2019, 95(1): 160-172.
|
| [3] |
Kumar S. Cellular and molecular pathways of renal repair after acute kidney injury [J]. Kidney Int, 2018, 93(1): 27-40.
|
| [4] |
Sudhini YR, Wei C, Reiser J. suPAR: an inflammatory mediator for kidneys [J]. Kidney Dis (Basel), 2022, 8(4): 265-274.
|
| [5] |
Kanno Y. The uPA/uPAR system orchestrates the inflammatory response, vascular homeostasis, and immune system in fibrosis progression [J]. Int J Mol Sci, 2023, 24(2): 1796.
|
| [6] |
Huang MJ, Ji YW, Chen JW, et al. Targeted VEGFA therapy in regulating early acute kidney injury and late fibrosis [J]. Acta Pharmacol Sin, 2023, 44(9): 1815-1825.
|
| [7] |
Basile DP, Friedrich JL, Spahic J, et al. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury [J]. Am J Physiol Renal Physiol, 2011, 300(3): F721-F733.
|
| [8] |
Venkatachalam MA, Weinberg JM, Kriz W, et al. Failed tubule recovery, AKI-CKD transition, and kidney disease progression [J]. J Am Soc Nephrol, 2015, 26(8): 1765-1776.
|
| [9] |
张轶男,朱国贞. 急性肾损伤向慢性肾脏病转变研究进展[J/OL]. 中华肾病研究电子杂志,2024, 13(2): 106-112.
|
| [10] |
Manetti M, Rosa I, Milia AF, et al. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma? [J]. Ann Rheum Dis, 2014, 73(9): 1700-1709.
|
| [11] |
Zhang G, Kim H, Cai X, et al. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy [J]. J Am Soc Nephrol, 2003, 14(5): 1254-1271.
|
| [12] |
Zhang G, Kim H, Cai X, et al. Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy [J]. J Am Soc Nephrol, 2003, 14(5): 1234-1253.
|
| [13] |
Smith HW, Marshall CJ. Regulation of cell signalling by uPAR [J]. Nat Rev Mol Cell Biol, 2010, 11(1): 23-36.
|
| [14] |
Larusch GA, Merkulova A, Mahdi F, et al. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR [J]. Am J Physiol Heart Circ Physiol, 2013, 305(3): H305-H320.
|
| [15] |
LaRusch GA, Mahdi F, Shariat-Madar Z, et al. Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis [J]. Blood, 2010, 115(24): 5111-5120.
|
| [16] |
Herkenne S, Paques C, Nivelles O, et al. The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis [J]. Sci Signal, 2015, 8(403): ra117.
|
| [17] |
Neugartn J, Golestaneh L. Gender and the prevalence and progression of renal disease [J]. Adv Chronic Kidney Dis, 2013, 20(5): 390-395.
|
| [18] |
Dixon EE, Wu H, Muto Y, et al. Spatially resolved transcriptomic analysis of acute kidney injury in a female murine model [J]. J Am Soc Nephrol, 2022, 33(2): 279-289.
|
| [19] |
Hayek SS, Sever S, Ko YA, et al. Soluble urokinase receptor and chronic kidney disease [J]. N Engl J Med, 2015, 373(20): 1916-1925.
|